Structural Characterization of Ceria-Supported Pt Nanoparticles by Flame-Assisted Spray Pyrolysis Using a Burner Diffusion Flame by Tsuyoshi Nagasawa (8680269)

“…TEM tomography of large Pt/CeO₂ has disclosed that Pt particles are inside of CeO₂ or partially embedded on the CeO₂ surface and also that CeO₂ at lower flame temperature has a polycrystalline structure. Average Pt size in large CeO₂ reduces from 10.4 to 5.5 nm with decreasing flame temperature from 1800 to 1550 K while CeO₂ size does not change significantly. …”

Structural Characterization of Ceria-Supported Pt Nanoparticles by Flame-Assisted Spray Pyrolysis Using a Burner Diffusion Flame by Tsuyoshi Nagasawa (8680269)

“…TEM tomography of large Pt/CeO₂ has disclosed that Pt particles are inside of CeO₂ or partially embedded on the CeO₂ surface and also that CeO₂ at lower flame temperature has a polycrystalline structure. Average Pt size in large CeO₂ reduces from 10.4 to 5.5 nm with decreasing flame temperature from 1800 to 1550 K while CeO₂ size does not change significantly. …”

Structural Characterization of Ceria-Supported Pt Nanoparticles by Flame-Assisted Spray Pyrolysis Using a Burner Diffusion Flame by Tsuyoshi Nagasawa (8680269)

“…TEM tomography of large Pt/CeO₂ has disclosed that Pt particles are inside of CeO₂ or partially embedded on the CeO₂ surface and also that CeO₂ at lower flame temperature has a polycrystalline structure. Average Pt size in large CeO₂ reduces from 10.4 to 5.5 nm with decreasing flame temperature from 1800 to 1550 K while CeO₂ size does not change significantly. …”

Structural Characterization of Ceria-Supported Pt Nanoparticles by Flame-Assisted Spray Pyrolysis Using a Burner Diffusion Flame by Tsuyoshi Nagasawa (8680269)

“…TEM tomography of large Pt/CeO₂ has disclosed that Pt particles are inside of CeO₂ or partially embedded on the CeO₂ surface and also that CeO₂ at lower flame temperature has a polycrystalline structure. Average Pt size in large CeO₂ reduces from 10.4 to 5.5 nm with decreasing flame temperature from 1800 to 1550 K while CeO₂ size does not change significantly. …”

Biocompatible and Antifouling Linear Poly(<i>N</i>‑(2-hydroxypropyl)methacrylamide)-Coated Capillaries via Aqueous RAFT Polymerization Method for Clinical Proteomics Analysis of No... by Mengqing Yang (13253917)

Subjects:

Biocompatible and Antifouling Linear Poly(<i>N</i>‑(2-hydroxypropyl)methacrylamide)-Coated Capillaries via Aqueous RAFT Polymerization Method for Clinical Proteomics Analysis of No... by Mengqing Yang (13253917)

Subjects:

Biocompatible and Antifouling Linear Poly(<i>N</i>‑(2-hydroxypropyl)methacrylamide)-Coated Capillaries via Aqueous RAFT Polymerization Method for Clinical Proteomics Analysis of No... by Mengqing Yang (13253917)

Subjects:

Biocompatible and Antifouling Linear Poly(<i>N</i>‑(2-hydroxypropyl)methacrylamide)-Coated Capillaries via Aqueous RAFT Polymerization Method for Clinical Proteomics Analysis of No... by Mengqing Yang (13253917)

Subjects:

Biocompatible and Antifouling Linear Poly(<i>N</i>‑(2-hydroxypropyl)methacrylamide)-Coated Capillaries via Aqueous RAFT Polymerization Method for Clinical Proteomics Analysis of No... by Mengqing Yang (13253917)

Subjects:

Biocompatible and Antifouling Linear Poly(<i>N</i>‑(2-hydroxypropyl)methacrylamide)-Coated Capillaries via Aqueous RAFT Polymerization Method for Clinical Proteomics Analysis of No... by Mengqing Yang (13253917)

Subjects:

Biocompatible and Antifouling Linear Poly(<i>N</i>‑(2-hydroxypropyl)methacrylamide)-Coated Capillaries via Aqueous RAFT Polymerization Method for Clinical Proteomics Analysis of No... by Mengqing Yang (13253917)

Subjects:

Biocompatible and Antifouling Linear Poly(<i>N</i>‑(2-hydroxypropyl)methacrylamide)-Coated Capillaries via Aqueous RAFT Polymerization Method for Clinical Proteomics Analysis of No... by Mengqing Yang (13253917)

Subjects:

Biocompatible and Antifouling Linear Poly(<i>N</i>‑(2-hydroxypropyl)methacrylamide)-Coated Capillaries via Aqueous RAFT Polymerization Method for Clinical Proteomics Analysis of No... by Mengqing Yang (13253917)

Subjects:

Validation of MN705 treatment effects in human proximal tubular epithelial cells during TGF- by Wencheng Jin (13136262)

Data Sheet 1_Semaglutide attenuates myocardial ischemia-reperfusion injury by inhibiting ferroptosis of cardiomyocytes via activation of PKC-S100A9 axis.pdf by Yan Liu (25061)

“…In vitro, experiments showed that semaglutide decreased the expression of S100A9 by activating the Protein Kinase C(PKC) pathway, thus inhibiting ferroptosis in cardiomyocytes.…”

Data Sheet 2_Semaglutide attenuates myocardial ischemia-reperfusion injury by inhibiting ferroptosis of cardiomyocytes via activation of PKC-S100A9 axis.docx by Yan Liu (25061)

“…In vitro, experiments showed that semaglutide decreased the expression of S100A9 by activating the Protein Kinase C(PKC) pathway, thus inhibiting ferroptosis in cardiomyocytes.…”

Table 1_Semaglutide attenuates myocardial ischemia-reperfusion injury by inhibiting ferroptosis of cardiomyocytes via activation of PKC-S100A9 axis.docx by Yan Liu (25061)

“…In vitro, experiments showed that semaglutide decreased the expression of S100A9 by activating the Protein Kinase C(PKC) pathway, thus inhibiting ferroptosis in cardiomyocytes.…”

Decreased myofibroblasts in the peritumoral region and high expression of MMP-7 in Pan02 S.C. tumor of <i>S100a4-Cre; Ext1</i>^<i>f/f</i> mice. by Ayumi Niwa (6256790)

“…<p>(A) Immunostaining of α-smooth muscle actin (αSMA)-positive spindle cells, i.e., myofibroblasts, in the peritumoral region of Pan02 S.C. pancreatic tumors in <i>S100a4-Cre; Ext1</i>^<i>f/f</i> and control mice (left). …”

Longer polyQ sequences increase the tendency of AR-NTD to form gels. by Carlos M. Roggero (11909585)

Image_4_v1_Systemic Immune Modulation Alters Local Bone Regeneration in a Delayed Treatment Composite Model of Non-Union Extremity Trauma.jpeg by Casey E. Vantucci (10528263)

“…This overall increase correlated with a decrease in bone volume (P = 0.057) at 6 weeks post-treatment and a significant decrease in mechanical strength at 12 weeks post-treatment compared to untreated rats. …”